Reset
Showing 10 of 70 academic articles

Machine learning in chemoinformatics and drug discovery

Yu‐Chen Lo, Stefano Rensi, Wen Torng, Russ Biagio Altman • Drug Discovery Today (2018)

Chemoinformatics is an established discipline focusing on extracting, processing and extrapolating meaningful data from chemical structures. With the rapid explosion of chemical 'big' data from HTS and combinatorial synthesis, machine learn...

OPENALEX cc-by DOI: https://doi.org/10.1016/j.drudis.2018.05.010 PMC: 6078794

Artificial intelligence in cancer target identification and drug discovery

Yujie You, Xin Lai, Yi Feng Pan, Huiru Zheng et al. • Signal Transduction and Targeted Therapy (2022)

Artificial intelligence is an advanced method to identify novel anticancer targets and discover novel drugs from biology networks because the networks can effectively preserve and quantify the interaction between components of cell systems ...

OPENALEX cc-by DOI: https://doi.org/10.1038/s41392-022-00994-0 PMC: 9090746

Artificial Intelligence in Drug Design

Gerhard Heßler, Karl H. Baringhaus • Molecules (2018)

Artificial Intelligence (AI) plays a pivotal role in drug discovery. In particular artificial neural networks such as deep neural networks or recurrent networks drive this area. Numerous applications in property or activity predictions like...

OPENALEX cc-by DOI: https://doi.org/10.3390/molecules23102520 PMC: 6222615

Cobdock: an accurate and practical machine learning-based consensus blind docking method

Sadettin Y. Ugurlu, David McDonald, Huangshu Lei, Alan M. Jones et al. • Journal of Cheminformatics (2024)

Abstract Probing the surface of proteins to predict the binding site and binding affinity for a given small molecule is a critical but challenging task in drug discovery. Blind docking addresses this issue by performing docking on binding r...

DOAJ Open Access (DOAJ) DOI: 10.1186/s13321-023-00793-x